ReVision Optics to Continue Enrollment of Phase 3 Trial of the Raindrop Near Vision Inlay

ReVision Optics, Inc., has received conditional approval from the FDA to continue and complete enrollment in its phase 3 clinical trial of the Raindrop Near Vision Inlay (formerly the PresbyLens), according to a news release. The prospective, multicenter trial is evaluating the safety and effectiveness of the patented,...

Full Story →